1-methyl-5,6,7,8-tetrahydroisoquinoline | 97288-85-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: 1-methyl-5,6,7,8-tetrahydroisoquinoline
• CAS: 97288-85-2
• 化学式: C₁₀H₁₃N
• 分子量: 147.22
• InChiKey: MJGMBHADZXAPNF-UHFFFAOYSA-N

物化性质

• 沸点：
  158 °C(Press: 14 Torr)
• 密度：
  1.010±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.6
• 重原子数：
  11
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  12.9
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为产物：
  描述：

  1-(2-乙烯基环己基)乙酮 在 四(三苯基膦)钯 、 盐酸羟胺 、 sodium acetate 、 sodium hydride 、 三乙胺 作用下， 以 四氢呋喃 、 甲醇 、 N,N-二甲基甲酰胺 、 mineral oil 为溶剂， 反应 30.5h， 生成 1-methyl-5,6,7,8-tetrahydroisoquinoline
  参考文献：
  名称：

  Investigation on Amino-Heck Cyclization of 1-(2-Vinylcyclohexyl)ketone Diethyl Phosphinyloximes

  摘要：

  Upon the treatment with Pd(PPh3)4 and Et3N in DMF at 80 degrees C, a range of trans-1-(2-vinylcyclohexyl)-substituted ketone diethylphosphinyloximes underwent the cyclization in a 6-endo pathway to afford 1-substituted tetrahydroisoquinolines in varying yields. Among which, the reactions of the substrates bearing the saturated alkyl groups were severely competed by hydrolysis and/or Beckmann rearrangement, while these undesired side reactions could be suppressed by introducing a beta-aryl moiety possibly due to the stabilizing pi-pi stacking interactions between the phosphoryl and/or vinyl group and the aryl rings.

  DOI：

  10.3987/com-11-12396

文献信息

• SILICON BASED DRUG CONJUGATES AND METHODS OF USING SAME
  申请人：BlinkBio, Inc.

  公开号：US20170202970A1

  公开（公告）日：2017-07-20

  Described herein are silicon based conjugates capable of delivering one or more payload moieties to a target cell or tissue. Contemplated conjugates may include a silicon-heteroatom core, one or more optional catalytic moieties, a targeting moiety that permits accumulation of the conjugate within a target cell or tissue, one or more payload moieties (e.g., a therapeutic agent or imaging agent), and two or more non-interfering moieties covalently bound to the silicon-heteroatom core.

  本文描述了基于硅的共轭物，能够将一个或多个有效载荷基团传递到靶细胞或组织。考虑到的共轭物可能包括一个硅-杂原子核心，一个或多个可选的催化基团，一个定位基团，允许共轭物在靶细胞或组织内积累，一个或多个有效载荷基团（例如，治疗剂或成像剂），以及与硅-杂原子核心共价结合的两个或更多个不干扰基团。
• [EN] ANTIBACTERIAL COMPOUNDS HAVING BROAD SPECTRUM OF ACTIVITY<br/>[FR] COMPOSÉS ANTIBACTÉRIENS À LARGE SPECTRE D'ACTIVITÉ
  申请人：ACRAF

  公开号：WO2016096686A1

  公开（公告）日：2016-06-23

  The present invention relates to novel antibacterial compounds, pharmaceutical compositions containing them and their use as antimicrobials.

  本发明涉及新型抗菌化合物，含有它们的药物组合物以及它们作为抗微生物药物的用途。
• Substituted 2-[monoannelated (3,4-,4,5-, and 5,6-)
  申请人：The Upjohn Company

  公开号：US05077407A1

  公开（公告）日：1991-12-31

  The present invention provides novel substituted 2-[monoannelated(3,4- 4,5-, and 5,6-)pyridylalkylenesulfinyl]-benzimidazoles with gastric acid inhibiting effects.

  本发明提供了一种新颖的取代2-[单环化(3,4- 4,5-, 和 5,6-)吡啶基烷基亚磺酰基]-苯并咪唑，具有抑制胃酸的作用。
• Mild and Selective Rhodium-Catalyzed Transfer Hydrogenation of Functionalized Arenes
  作者：Yuhan Wang、Zhiqian Chang、Yan Hu、Xiao Lin、Xiaowei Dou

  DOI：10.1021/acs.orglett.1c00341

  日期：2021.3.5

  Diboron-mediated rhodium-catalyzed transfer hydrogenation of functionalized arenes is reported. In addition to good functional group tolerance, the reaction features operational simplicity and controllable chemoselectivity. The general applicability of this procedure is demonstrated by the selective hydrogenation of a range of arenes, including functionalized benzenes, biphenyls, and polyaromatics

  报道了二硼介导的铑催化的官能化芳烃的转移氢化。除了良好的官能团耐受性外，该反应还具有操作简便和可控的化学选择性的特点。该方法的一般适用性通过一系列芳烃的选择性加氢来证明，包括功能化的苯，联苯和多芳烃。
• Route to Highly Substituted Pyridines
  作者：Justin A. Hilf、Michael S. Holzwarth、Scott D. Rychnovsky

  DOI：10.1021/acs.joc.6b01370

  日期：2016.11.4

  Pyridine rings are common structural motifs found in a number of biologically active compounds, including some top-selling pharmaceuticals. We have developed a new approach to access substituted pyridines. The method aims to provide a reliable synthesis of a diverse range of substituted pyridines through a three-step procedure. Readily available enones are first converted into 1,5-dicarbonyls through

  吡啶环是在许多生物活性化合物（包括一些畅销药物）中发现的常见结构基序。我们已经开发出一种新的方法来获得取代的吡啶。该方法旨在通过三步法提供可靠的合成范围广泛的取代吡啶。易于获得的烯酮首先通过两步Hosomi-Sakurai烯丙基化/氧化裂解序列转化为1,5-二羰基，然后使用盐酸羟胺将其环化为相应的吡啶。使用该方法已经合成了多种取代的吡啶。